Cite
HARVARD Citation
Othman, T. et al. (2021). Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents. American journal of hematology. 96 (5), pp. E140-E143. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Othman, T. et al. (2021). Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents. American journal of hematology. 96 (5), pp. E140-E143. [Online].